Workers and families with private health insurance would reap savings on prescription drugs from a little-noticed provision in President Joe Biden’s sweeping social agenda bill. It’s meant to break the cycle of annual price increases for widely used medicines.
Health care costs rise every year, but the nation’s biggest employers still see insurance coverage as an important benefit to provide.
New bipartisan legislation aims to outlaw several practices employed by hospitals critics say harm competition, including requirements for payers to contract with affiliated providers.
A pair of new companies are being launched to tackle high drug costs, the latest sign of employer frustration with the middlemen, known as PBMs, whose job it is to keep down the spending.
More employers and health care payers are carving out their pharmacy benefit management as they seek more transparency.
As members of Congress decide how to expand access to telehealth after the pandemic, one of the biggest questions has centered around how much Medicare providers should be paid for virtual care.
Many on the frontlines are not just tired but are also in precarious financial straits and lack the resources to “build back better.”
Democrats’ next big bill could include drug price negotiations and other industry curbs. Pharma may not be able to fight it off this time.
Under unprecedented economic pressures due to the pandemic large employers are looking for new ways to buy the best quality health care for their employees.
“I have no doubt that it’s going to be a pretty epic fight.”